[go: up one dir, main page]

DE69535360D1 - Synthetische peptide und impfstoffe welche diese beinhalten - Google Patents

Synthetische peptide und impfstoffe welche diese beinhalten

Info

Publication number
DE69535360D1
DE69535360D1 DE69535360T DE69535360T DE69535360D1 DE 69535360 D1 DE69535360 D1 DE 69535360D1 DE 69535360 T DE69535360 T DE 69535360T DE 69535360 T DE69535360 T DE 69535360T DE 69535360 D1 DE69535360 D1 DE 69535360D1
Authority
DE
Germany
Prior art keywords
vaccines
contain
synthetic peptides
present
chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535360T
Other languages
English (en)
Other versions
DE69535360T2 (de
Inventor
Juan Anton Cooper
Wendy Anne Relf
Michael Frances Good
Allan James Saul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council Of Queensland Institute Of Med Au
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Walter and Eliza Hall Institute of Medical Research
Queensland Institute of Medical Research QIMR
CSL Ltd
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Walter and Eliza Hall Institute of Medical Research, Queensland Institute of Medical Research QIMR, CSL Ltd, University of Melbourne filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Application granted granted Critical
Publication of DE69535360D1 publication Critical patent/DE69535360D1/de
Publication of DE69535360T2 publication Critical patent/DE69535360T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69535360T 1994-10-14 1995-10-16 Synthetische peptide und impfstoffe welche diese beinhalten Expired - Lifetime DE69535360T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM8851A AUPM885194A0 (en) 1994-10-14 1994-10-14 Synthetic peptides and vaccines comprising same
AUPM885194 1994-10-14
PCT/AU1995/000681 WO1996011944A1 (en) 1994-10-14 1995-10-16 Synthetic peptides and vaccines comprising same

Publications (2)

Publication Number Publication Date
DE69535360D1 true DE69535360D1 (de) 2007-02-15
DE69535360T2 DE69535360T2 (de) 2008-02-14

Family

ID=3783369

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535360T Expired - Lifetime DE69535360T2 (de) 1994-10-14 1995-10-16 Synthetische peptide und impfstoffe welche diese beinhalten

Country Status (10)

Country Link
US (1) US6174528B1 (de)
EP (1) EP0787139B1 (de)
JP (2) JP4463877B2 (de)
CN (1) CN1118474C (de)
AT (1) ATE350390T1 (de)
AU (2) AUPM885194A0 (de)
CA (1) CA2202504C (de)
DE (1) DE69535360T2 (de)
ES (1) ES2281900T3 (de)
WO (1) WO1996011944A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM885194A0 (en) 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
US6872806B1 (en) 1999-06-25 2005-03-29 The Governors Of The University Of Alberta Polypeptide compositions formed using a coiled-coil template and methods of use
US6617432B1 (en) * 1999-10-15 2003-09-09 University Of Pittsburgh Nuclear matrix proteins polynucleotide sequences encoding them and their use
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
ES2330083T3 (es) * 2000-10-27 2009-12-04 Novartis Vaccines And Diagnostics S.R.L. Acidos nucleicos y proteinas de estreptococos de los grupos a y b.
EP2301972A1 (de) 2002-08-12 2011-03-30 The Council Of The Queensland Institute Of Medical Research Verfahren zur Herstellung von immunogenen Lipopeptiden, die T-Helper und B-Zell-Epitope enthalten
AU2003260102A1 (en) * 2002-08-26 2004-03-11 Chiron Corporation Conserved and specific streptococcal genomes
US7255867B2 (en) * 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
ES2505695T3 (es) 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2005113602A1 (en) * 2004-05-21 2005-12-01 Cytovax Biotechnologies Inc. Coiled-coil microbial antigens
CA2575548A1 (en) 2004-07-29 2006-07-27 John L. Telford Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1807446A2 (de) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogene und therapeutische zusammensetzungen für pyogene streptokokken
KR20070122563A (ko) 2005-04-19 2007-12-31 일라이 릴리 앤드 캄파니 질병에의 면역학적 개입을 위한 1가 및 다가 합성 다당류항원
PT2054431E (pt) * 2006-06-09 2011-11-03 Novartis Ag Confórmeros de adesinas bacterianas
WO2008108830A2 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
EP2537857B1 (de) * 2007-12-21 2017-01-18 GlaxoSmithKline Biologicals SA Mutante Formen von Streptolysin O
CN103160571A (zh) * 2011-12-09 2013-06-19 彩虹天健康科技研究(北京)有限责任公司 磷酸化肌球蛋白和驱动蛋白的激酶的发现
MX392514B (es) * 2014-04-15 2025-03-24 Univ Griffith Vacuna para estreptococo del grupo a.
EP4420675A4 (de) * 2021-08-23 2025-10-15 Yichen Therapeutics Ltd Epitopmodifikation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210183A (en) * 1987-05-13 1993-05-11 Hightech Receptor Ab Protein Arp, with immunoglobulin A binding activity, the corresponding vectors and hosts, reagent kit and pharmaceutical composition
US5817318A (en) * 1989-05-03 1998-10-06 Connaught Laboratories Limited Synthetic peptides for an HIV-1 vaccine
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
US5821088A (en) * 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
DK0646176T3 (da) * 1992-03-13 2004-11-08 Univ Rockefeller Levering og ekspression af et hybridoverfladeprotein på overfladen af grampositive bakterier
WO1993021220A1 (en) 1992-04-08 1993-10-28 The Council Of The Queensland Institute Of Medical Research Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
AU3741793A (en) * 1992-04-08 1993-11-18 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
WO1993025683A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology A gene which prevents programmed cell death
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
DE69331733T2 (de) 1992-09-16 2002-08-22 The University Of Tennessee Research Corp., Knoxville Rekombinantes vielwertiges m-protein-vakzin
WO1994006465A1 (en) 1992-09-16 1994-03-31 The University Of Tennessee Research Corporation Antigen of hybrid m protein and carrier for group a streptococcal vaccine
EP0702693A1 (de) * 1993-06-09 1996-03-27 Connaught Laboratories Limited Synthetische hiv-1-tandempeptede
GB9321469D0 (en) * 1993-10-18 1993-12-08 Zeneca Ltd Insecticidal proteins
AUPM885194A0 (en) 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis

Also Published As

Publication number Publication date
JP2009067810A (ja) 2009-04-02
JP4463877B2 (ja) 2010-05-19
WO1996011944A1 (en) 1996-04-25
DE69535360T2 (de) 2008-02-14
AU704688B2 (en) 1999-04-29
JPH10512543A (ja) 1998-12-02
CN1118474C (zh) 2003-08-20
CA2202504C (en) 2008-12-09
ES2281900T3 (es) 2007-10-01
EP0787139B1 (de) 2007-01-03
EP0787139A1 (de) 1997-08-06
AUPM885194A0 (en) 1994-11-10
ATE350390T1 (de) 2007-01-15
AU3645595A (en) 1996-05-06
CN1168674A (zh) 1997-12-24
CA2202504A1 (en) 1996-04-25
US6174528B1 (en) 2001-01-16
EP0787139A4 (de) 2002-10-09

Similar Documents

Publication Publication Date Title
ATE350390T1 (de) Synthetische peptide und impfstoffe welche diese beinhalten
DE69434295D1 (de) Von menschlichen T-Zellen immunodominante Epitopen des Virus der C-Hepatitis
ATE188612T1 (de) Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend
ATE178907T1 (de) Rezeptorbindende region des diphtherietoxius
FI955101A7 (fi) Immunogeenisia LHRH-peptidirakenteita ja synteettisiä immunosysteemin yleisstimulaattoreita rokotteita varten
TR200901109T1 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
DE69532996D1 (de) Peptidanaloge des menschlichen basischen myelinproteins
TR199801722T2 (xx) Peptit imm�nojenler.
IL103510A0 (en) Pharmaceutical compositions containing antibodies for causing immunosuppression
NL300830I2 (nl) Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten
GB2301591A (en) Cytotoxic T-cell epitopes
NO942644D0 (no) Farmasöytiske bacteriocinsammensetninger
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
YU48525B (sh) Protein, dnk koji kodira protein, rekombinantni vektor koji obuhvata dnk i postupak za proizovodnju proteina
GR3029727T3 (en) Synthetic peptides and vaccines against parvovirus.
MY101874A (en) Vaccine
DE69009795D1 (de) Muramylpeptid-Derivate und diese enthaltende immunregulierende Zusammensetzungen.
IL149379A0 (en) Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
GB9511909D0 (en) Vaccine
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
IL126250A0 (en) Antibodies against avirulence or pathogenicity proteins of plant pathogens
DE69323688D1 (de) Epitop-Peptide von menschlichem Parvovirus
GB9604518D0 (en) Novel compounds
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
SE9702240D0 (sv) Vaccine compositions III

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MED, AU